1 of 1
Story summary
- At the CES show, gadgets such as a smart scale and an AI hormone tracker were showcased.
- Experts raised concerns about accuracy and data privacy.
- The Food and Drug Administration (FDA) announced relaxed regulations on low-risk wellness products.
- Sylvia Kang, CEO of Mira, emphasized the hormone tracker for women trying to conceive.
- Other innovations aim to improve healthcare access in underserved areas and must not replace professional medical advice.
